The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study
Edward Burn(University of Oxford), Rafael Pinedo‐Villanueva(Nuffield Orthopaedic Centre), Daniel Prieto‐Alhambra(Nuffield Orthopaedic Centre), Nigel Arden(Nuffield Orthopaedic Centre), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), David W. Murray(Nuffield Orthopaedic Centre), Alan J. Silman(Nuffield Orthopaedic Centre)
Cited by 29
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k